SELLAS Life Sciences Group, Inc. - Common Stock (SLS) stock analysis
SLS · SELLAS Life Sciences Group, Inc. - Common Stock
Latest recorded price: USD 7.47
Sector and industry: Healthcare · Biotechnology
Fiscal 2023 figures: revenue growth -100.0%. The model flags 1 risk signal for this company (1 high severity).